RT1-Ac Inhibitors
RT1-Ac inhibitors belong to a specialized class of chemical compounds that function by targeting and modulating specific molecular interactions within the RT1-Ac subunit, a key component of the major histocompatibility complex (MHC) in certain species, particularly rodents. The RT1-Ac locus is part of the genetic encoding system for proteins involved in antigen processing and presentation, a crucial aspect of immune recognition. Structurally, these inhibitors often contain molecular motifs designed to interfere with the binding capabilities of the RT1-Ac proteins, thereby altering the way in which peptides are processed or presented within this complex. Their design is rooted in understanding the three-dimensional conformation of the RT1-Ac molecule, and how slight modifications in charge, hydrophobicity, or steric hindrance can inhibit its normal function at a biochemical level. By manipulating interactions at the molecular interface, RT1-Ac inhibitors can affect the structural dynamics of the MHC-peptide complexes.
At the chemical level, the efficacy of RT1-Ac inhibitors depends on a delicate balance of ligand-receptor affinity, solubility, and stability under physiological conditions. These inhibitors are often fine-tuned to optimize their interaction with the active sites or allosteric regions of the RT1-Ac protein. In addition, their chemical structure is designed to resist degradation from cellular enzymes, ensuring prolonged engagement with the target protein. Understanding these inhibitors requires a deep dive into computational modeling, structural biology, and organic chemistry to design compounds that achieve the desired inhibition. This chemical class represents a fascinating intersection between molecular recognition, protein chemistry, and complex ligand design.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
This immunosuppressant could diminish RT1-Ac expression by selectively targeting the calcineurin pathway, thereby repressing the transcriptional activation of genes associated with MHC molecule production. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin may lead to a decrease in RT1-Ac synthesis by curtailing the translation of mRNA transcripts integral to MHC molecule assembly. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Likely to curtail RT1-Ac expression by binding to FKBP12 and forming a complex that inhibits calcineurin, thus dampening the activity of NFAT, a transcription factor essential for MHC expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This glucocorticoid may truncate RT1-Ac expression through transrepression of NF-κB, a transcription factor that can induce MHC class I gene expression. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
By impeding purine nucleotide synthesis, azathioprine could hamper the proliferation of immune cells responsible for RT1-Ac expression, leading to its reduced presence. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
This compound may truncate the expression of RT1-Ac by curbing the de novo pathway of guanosine nucleotide synthesis, which is vital for the proliferation of cells that express MHC molecules. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Through its action as a dihydrofolate reductase inhibitor, methotrexate could suppress RT1-Ac by limiting the availability of tetrahydrofolate, essential for the synthesis of nucleotides and subsequent expression of MHC genes. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine might impede the endosomal acidification process, which is pivotal for the antigen processing, potentially leading to a reduction in RT1-Ac surface expression. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
By obstructing dihydroorotate dehydrogenase, leflunomide could lead to reduced synthesis of pyrimidines, thereby curtailing the proliferation of cells expressing RT1-Ac. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine may interfere with the glycosylation of MHC molecules, possibly leading to a misfolded RT1-Ac that is targeted for degradation instead of being presented on the cell surface. | ||||||